PAG
ROIV icon

Private Advisor Group’s Roivant Sciences ROIV Stock Holding History

Private Advisor Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Sell
13,840
-14,324
-51% -$423K ﹤0.01% 1812
2026
Q1 		$780K Buy
28,164
+16,219
+136% +$417K ﹤0.01% 1579
2025
Q4 		$259K Sell
11,945
-8,426
-41% -$166K ﹤0.01% 2259
2025
Q3 		$308K Buy
20,371
+5,651
+38% +$70K ﹤0.01% 2067
2025
Q2 		$166K Buy
+14,720
New +$160K ﹤0.01% 2266

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Private Advisor Group's ROIV Position: Q2 2026 in Review

Private Advisor Group reduced its Roivant Sciences (ROIV) stake by 51% in Q2 2026, selling an estimated $423K and leaving 13,840 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Private Advisor Group first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. The position peaked at $780K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Private Advisor Group held 13,840 shares of Roivant Sciences worth $490K as of Q2 2026.
  • Private Advisor Group sold 14,324 Roivant Sciences shares in Q2 2026, an estimated $423K.
  • Roivant Sciences made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1812 holding.
  • Private Advisor Group first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
  • Private Advisor Group's Roivant Sciences position peaked at $780K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.